Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2.

Ameratunga, Rohan; Woon, See-Tarn; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S

Ameratunga, Rohan; Woon, See-Tarn; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S.

Afiliación

Ameratunga R; Department of Clinical Immunology, Auckland Hospital, Grafton Auckland, New Zealand.
Woon ST; Department of Virology and Immunology, Auckland Hospital, Grafton Auckland, New Zealand.
Steele R; Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Lehnert K; Department of Virology and Immunology, Auckland Hospital, Grafton Auckland, New Zealand.
Leung E; Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Brooks AES; Department of Virology and Immunology, Auckland Hospital, Grafton Auckland, New Zealand.

Expert Rev Clin Immunol ; 18(6): 557-565, 2022 06.

Article en En | MEDLINE | ID: mdl-35510369

Asunto(s)

COVID-19; Enfermedades del Sistema Inmune; Vacunas; COVID-19/terapia; Humanos; Inmunización Pasiva; SARS-CoV-2; Linfocitos T; Sueroterapia para COVID-19

Palabras clave

COVID-19; Omicron; SARS-CoV2; Vaccines; immunodeficiency; plasma therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 / Enfermedades del Sistema Inmune Límite: Humans Idioma: En Revista: Expert Rev Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google